Pediatr. praxi. 2025;26(1):27-32 | DOI: 10.36290/ped.2025.006

Importance and risks of enterobacteria for healthy development of newborn gut microbiota

Ing. Jan Vinkler1, Ing. Nikol Modráčková, Ph.D.1, MUDr. Peter Korček, Ph.D.2, prof. MUDr. Zbyněk Straňák, CSc., MBA2, doc. Ing. Věra Neužil Bunešová, Ph.D.1
1 Katedra mikrobiologie, výživy a dietetiky, Česká zemědělská univerzita v Praze, Praha-Suchdol
2 Ústav pro péči o matku dítě, Praha

The gut microbiome plays a key role in a person's long-term physical and psychological health. Its appropriate composition during the initial colonization of the gastrointestinal tract of newborns with the sufficient representation of the taxa with commensal or probiotic potential is essential for defence against infections and proper development of the immune system. Enterobacteria form an integral part of the intestinal microbiota and play a vital role in the initial colonization of the newborn gut. At the same time, these are potential pathogens that can cause serious infections. This article describes the functions of enterobacteria in the microbiota of infants, the risks associated with their excessive presence, and strategies for preventing infections. Furthermore, factors affecting microbiota formation in children are discussed, including the delivery method and the effect of antibiotics. Research shows that promoting natural childbirth, breastfeeding, and probiotic use can positively influence the gut microbiota and eliminate potential risks associated with enterobacteria. The article provides an overview of current knowledge about enterobacteria in the microbiota of infants and highlights the need for further research and the sharing of new knowledge in clinical practice to ensure the healthy development of children.

Keywords: enterobacteria, newborn microbiome, infant infections, immune system, initial colonisation, antibiotic resistance.

Accepted: March 6, 2025; Published: March 19, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vinkler J, Modráčková N, Korček P, Straňák Z, Bunešová VN. Importance and risks of enterobacteria for healthy development of newborn gut microbiota. Pediatr. praxi. 2025;26(1):27-32. doi: 10.36290/ped.2025.006.
Download citation

References

  1. Gensollen T, Lyer SS, Kasper DL, et al. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539-544. Go to original source... Go to PubMed...
  2. Guentzel MN. Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston. 1996. Chapter 26.
  3. Baldelli V, Scaldaferri F, Putignani L, et al. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms. 2021;9(4):697. Go to original source... Go to PubMed...
  4. Seenivasan B, RM Saravana K, Snega Priya P, et al. Gut Enterobacteriaceae and uraemic toxins - Perpetrators for ageing, Experimental Gerontology. 2023;173:112088. Go to original source... Go to PubMed...
  5. Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord. 2015;30(3):350-358. Go to original source... Go to PubMed...
  6. De Angelis M, Piccolo M, Vannini L, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013;8(10):e76993. Go to original source... Go to PubMed...
  7. Hernandez-Alonso E, Bourgeois-Nicolaos N, Lepainteur M, et al. Contaminated Incubators: Source of a Multispecies Enterobacter Outbreak of Neonatal Sepsis. Microbiol Spectr. 2022;10(4):e0096422. Go to original source... Go to PubMed...
  8. Matamoros S, Gras-Leguen C, Le Vacon F, et al. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol. 2013;21(4):167-173. Go to original source... Go to PubMed...
  9. Zhong H, Penders J, Shi Z, et al. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome. 2019;7(1):2. Go to original source... Go to PubMed...
  10. Neu J, Rushing J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol. 2011;38(2):321-331. Go to original source... Go to PubMed...
  11. Arrieta MC, Stiemsma LT, Amenyogbe N, et al. The intestinal microbiome in early life: health and disease. Front Immunol. 2014;5:427. Go to original source... Go to PubMed...
  12. Octavia S, Lan R. The Family Enterobacteriaceae. In: Rosenberg E, DeLong EF, Lory S, et al. (editors) The Prokaryotes. Springer, Berlin, Heidelberg. 2014. Go to original source...
  13. Roux B, Walsh CT. p-aminobenzoate synthesis in Escherichia coli: kinetic and mechanistic characterization of the amidotransferase PabA. Biochemistry. 1992;31(30):6904-6910. Go to original source... Go to PubMed...
  14. Patel A, Singhania R, Pandey E, et al. Enterobacteriaceae, coliforms and E. coli Introduction, Batt C, Tortorello M. (editors), Encyclopedia of Food Microbiology (Second Edition), Academic Press. 2014: 659-666. Go to original source...
  15. Stewart V. Regulation of nitrate and nitrite reductase synthesis in enterobacteria. Antonie Van Leeuwenhoek. 1994;66(1-3):37-45. Go to original source... Go to PubMed...
  16. Pradhan S, Weiss AA. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids. mBio. 2020;11(4):e01470-20. Go to original source... Go to PubMed...
  17. Melville JM, Moss TJ. The immune consequences of preterm birth. Front Neurosci. 2013;7:79. Go to original source... Go to PubMed...
  18. Stewart C, Marrs E, Nelson A, et al. Development of the Preterm Gut Microbiome in Twins at Risk of Necrotising Enterocolitis and Sepsis. PLoS ONE. 2013;8(8):e73465. Go to original source... Go to PubMed...
  19. Hill CJ, Lynch DB, Murphy K, et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome 5. 2017. Go to original source... Go to PubMed...
  20. McClure P. 10 - Escherichia coli: virulence, stress response and resistance. In Woodhead Publishing Series in Food Science, Technology and Nutrition, Understanding Pathogen Behaviour, Woodhead Publishing. 2005:240-278. Go to original source...
  21. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol 13. 2013:349-361. Go to original source... Go to PubMed...
  22. Taylor WI, Achanzar D. Catalase test as an aid to the identification of Enterobacteriaceae. Appl Microbiol. 1972;24(1):58-61. Go to original source... Go to PubMed...
  23. Gough D, Cotter T. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis 2. 2011: e213. Go to original source... Go to PubMed...
  24. Iredell J, Brown J, Tagg K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ. 2016;352:h6420. Go to original source... Go to PubMed...
  25. Davin-Regli A, Lavigne JP, Pagès JM. Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance. Clin Microbiol Rev. 2019;32(4):e00002-19. Go to original source... Go to PubMed...
  26. Girlich D, Ouzani S, Emeraud C, et al. Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort study. Lancet Microbe. 2021;2(10):e536-e544. Go to original source... Go to PubMed...
  27. Kaper J, Nataro J, Mobley H. Pathogenic Escherichia coli. Nat Rev Microbiol 2. 2004:123-140 Go to original source... Go to PubMed...
  28. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11. 1998. Go to original source... Go to PubMed...
  29. Geurtsen J, de Been M, Weerdenburg E, et al. Genomics and pathotypes of the many faces of Escherichia coli. FEMS Microbiol Rev. 2022;46(6):fuac031. Go to original source... Go to PubMed...
  30. Rousseaux A, Brosseau C, Le Gall S, et al. Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents. Front Immunol. 2021;12:680911. Go to original source... Go to PubMed...
  31. Baud O, Aujard Y. Neonatal bacterial meningitis. Handb Clin Neurol. 2013;112:1109-1113. Go to original source... Go to PubMed...
  32. Poolman JT, Wacker M. Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field. J Infect Dis. 2016;213(1):6-13. Go to original source... Go to PubMed...
  33. Fu J, Li L, Huo D, et al. Meningitic Escherichia coli α-hemolysin aggravates blood-brain barrier disruption via targeting TGFβ1-triggered hedgehog signaling. Mol Brain. 2021;14(1):116. Go to original source... Go to PubMed...
  34. Helena De Oliveira L, Jauregui B, Carvalho AF, et al. Impact and effectiveness of meningococcal vaccines: a review. Rev Panam Salud Publica. 2017;41:e158. Go to original source... Go to PubMed...
  35. Dekker JP, Frank KM. Salmonella, Shigella, and yersinia. Clin Lab Med. 2015;35(2):225-246. Go to original source... Go to PubMed...
  36. Peterson JW. Bacterial Pathogenesis. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston. 1996. Chapter 7.
  37. Abbas R, Chakkour M, Zein El Dine H, et al. General Overview of Klebsiella pneumonia: Epidemiology and the Role of Siderophores in Its Pathogenicity. Biology. 2024;13(2):78. Go to original source... Go to PubMed...
  38. Murphy CN, Clegg S. Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation. Future Microbiol. 2012;7(8):991-1002. Go to original source... Go to PubMed...
  39. Samonis G, Karageorgopoulos D, Kofteridis D, et al. Citrobacter infections in a general hospital: Characteristics and outcomes. European journal of clinical microbiology & infectious diseases. 2008;28:61-68. Go to original source... Go to PubMed...
  40. Ekundayo TC, Ijabadeniyi OA. Global and regional prevalence of Cronobacter sakazakii in powdered milk and flour. Sci Rep 14. 2024:6865. Go to original source... Go to PubMed...
  41. Healy B, Cooney S, O'Brien S, et al. Cronobacter (Enterobacter sakazakii): an opportunistic food-borne pathogen. Foodborne Pathog Dis. 2010;7(4):339-350. Go to original source... Go to PubMed...
  42. World Health Organization. Strengthening health systems to improve health outcomes: WHO's framework for action. 2007. https://iris.who.int/bitstream/handle/10665/44032/9789241563796_eng.pdf?sequence=1. Cited 4 July 2024.
  43. Dunn AB, Jordan S, Baker BJ, et al. The Maternal Infant Microbiome: Considerations for Labor and Birth. MCN Am J Matern Child Nurs. 2017;42(6):318-325. Go to original source... Go to PubMed...
  44. Mueller NT, Differding MK, Sun H, et al. Maternal Bacterial Engraftment in Multiple Body Sites of Cesarean Section Born Neonates after Vaginal Seeding-a Randomized Controlled Trial. mBio. 2023;14(3):e0049123. Go to original source... Go to PubMed...
  45. O'Sullivan A, Farver M, Smilowitz JT. The Influence of Early Infant-Feeding Practices on the Intestinal Microbiome and Body Composition in Infants. Nutr Metab Insights. 2015;8(Suppl 1):1-9. Go to original source... Go to PubMed...
  46. Abdel.hamid AG, El-Masry SS, El-Dougdoug NK. Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining. EPMA J. 2019;10(4):337-350. Go to original source... Go to PubMed...
  47. Aleman RS, Yadav A. Systematic Review of Probiotics and Their Potential for Developing Functional Nondairy Foods. Applied Microbiology. 2024;4(1):47-69. Go to original source...
  48. Hung YP, Lee CC, Lee JC, et al. The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales. Antibiotics. 2021;10(9):1086. Go to original source... Go to PubMed...
  49. Cukrowska B, Lodinová-Zádniková R, Enders C, et al. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol. 2002;55(2):204-209. Go to original source... Go to PubMed...
  50. World Health Organization. Antimicrobial resistance and primary health care. 2018. https://www.who.int/docs/default-source/primary-health-care-conference/amr.pdf Cited July 4, 2024.
  51. Dawczynski K, Proquitté H, Roedel J, et al. Intensified colonisation screening according to the recommendations of the German Commission for Hospital Hygiene and Infectious Diseases Prevention (KRINKO): identification and containment of a Serratia marcescens outbreak in the neonatal intensive care unit, Jena, Germany, 2013-2014. Infection. 2016;44(6):739-746. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.